2022-05-19 |
|
|
Zydus infringement trial concerning U.S. Patent Nos. 8,101,659, 8,796,331, 8,877,938 and 9,388,134 to May… 29 October 2019
1:19-cv-02053
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2022-05-04 |
252 |
Stipulation to EXTEND Time |
infringement trial concerning U.S. Patent Nos. 8,101,659; 8,796,331; 8,877,938; and 9,388,134 in accordance… 29 October 2019
1:19-cv-02053
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2022-05-10 |
253 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
Regarding Defendant DRL's Infringement of U.S. Patent No. 8,796,331 by Novartis Pharmaceuticals Corporation.… 29 October 2019
1:19-cv-02053
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2022-05-10 |
254 |
Order |
Regarding Defendant DRL's Infringement of U.S. Patent No. 8,796,331. Signed by Judge Richard G. Andrews on 5… 29 October 2019
1:19-cv-02053
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2022-05-11 |
257 |
Stipulation to EXTEND Time |
Zydus infringement trial concerning U.S. Patent Nos. 8,101,659, 8,796,331, 8,877,938 and 9,388,134 to May… 29 October 2019
1:19-cv-02053
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |